Most Recent
AstraZeneca has slammed Pharmacor's defence to claims it infringed a patent for blockbuster diabetes drug Forxiga as a "complete shot in the dark", as the drug maker unsuccessfully fought orders to produce documents from a UK case.
A recent judgment that clarified the date for assessing best method knowledge for divisional patents appears to create new difficulties for patent applicants, lawyers say.
Pharmacor, which is facing infringement claims by AstraZeneca over its plans to launch a generic version of diabetes drug Forxiga, can tweak its cross-claim to challenge a patent term extension.
Pharmacor is resisting AstraZeneca’s notice to produce in an intellectual property fight over diabetes drug Forxiga, claiming privilege over material evidencing its consideration of a new claim challenging the validity of a patent extension.
Pharmacor wants to amend its defence in AstraZeneca's suit over the Australian drug maker's plans to launch a generic version of diabetes drug Forxiga so that it can argue a patent extension for the drug should not have been granted.
AstraZeneca has won an interlocutory injunction barring Pharmacor from making a generic version of its blockbuster diabetes drug Forxiga while a patent case over the drug proceeds.
Fashion retailer City Beach is challenging a $14 million penalty secured by the ACCC in the consumer regulator's first enforcement action for breaches of button battery safety standards.
A court has slapped Qoin cryptocurrency issuer BPS Financial with a $14 million penalty for “serious and unlawful misconduct”, including making misleading statements about the product and providing financial advice without a license.
Construction PRO
An iProsperity director must pay $5.3 million to ZACD for his conduct in convincing the Singapore-based real estate investment firm to cough up $37.5 million for its $300 million purchase of the AccorInvest hotels portfolio.
Mining equipment supplier Southern Cross Industrial has lost its suit alleging an industrial lighting manufacturer infringed its patent for a portable light tower, with a judge finding the patent invalid.